NCT03817099

Brief Summary

Ramadan fasting is an important event for Muslims. During Ramadan, all healthy Muslims are asked to abstain from food and drink throughout the day and eat only during daybreak (also know as Sahur in Malay/Arabic language) and after sunset (also know as Iftar in Malay/Arabic language). Patients with type 2 diabetes (T2DM) can be exempted from fasting but most of them do not perceive themselves as sick, and they continue to fast. With so many Muslims with diabetes choosing to fast, there is an immediate need for evidence-based nutrition practice guidelines. This study is conducted to determine the feasibility of implementing the Ramadan Nutrition Plan named My Dia-RNP that is also incorporating diabetes-specific nutrition formula on dietary adherence and acceptability in patients with type 2 diabetes mellitus. We hypothesized that My Dia-RNP is feasible to be practiced by patients with type 2 diabetes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
53

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2019

Completed
Last Updated

August 12, 2019

Status Verified

August 1, 2019

Enrollment Period

8 months

First QC Date

January 9, 2019

Last Update Submit

August 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of participants completed the study

    The ability and likelihood to complete a study successfully with the aim to achieve at least 80% of the study retention rates.

    12 weeks

Secondary Outcomes (7)

  • Rate of participants adhered to the intervention

    12 weeks

  • Efficacy potential on the rate of hypoglycemia

    12 weeks

  • Efficacy potential on the fructosamine level

    4 weeks

  • Efficacy potential on fasting glucose

    12 weeks

  • Efficacy potential on glycemic control

    12 weeks

  • +2 more secondary outcomes

Study Arms (2)

My Dia-RNP

EXPERIMENTAL

In the My Dia-RNP group, participants will undergo the pre-RNP assessment 2 weeks before Ramadan. They will be given a nutrition education based on the Ramadan Nutrition Plan Guide published by IDF-DAR Practical Guidelines. They will also be asked to incorporate diabetes-specific nutrition formula (Nutren untuk Diabetik®) within the prescribed calories before Ramadan period to help them familiarise with a dietary change.

Other: Nutrition Intervention based on My Dia-RNP

Usual Care

ACTIVE COMPARATOR

Participant in this group will continue in a usual care (UC) group. They will receive dietary advice based on the Practical Guide to Diabetes Management in Ramadan produced by Ministry of Health (2015).

Other: Usual Care

Interventions

Subjects in this group will be advised to follow My Dia-RNP and to incorporate diabetes-specific formula (Nutren®Untuk Diabetik)

My Dia-RNP

Subjects in the group continue with the usual care

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All Muslim patients aged \> 18 years old
  • Have a confirmed diagnosis of T2D for at least 6 months
  • BMI \> 18.5 but \< 40 kg/m2
  • HbA1c of \> 6.5% but \< 10%
  • On a stabilised dose of oral anti-diabetes agents (OAD) for the past 2 months prior to the study
  • Willing to fast for at least 15 days during Ramadan

You may not qualify if:

  • History of hypoglycaemia leading to hospitalization during the previous Ramadan
  • Liver disease
  • Abnormal liver function test or renal profiles
  • On insulin injection
  • Reported abnormal thyroid stimulating hormones
  • Use of medications known to effect lipid or glucose metabolism such as steroid
  • Pregnancy or the desire to become pregnant in the next 3 months
  • On any weight loss program or weight loss medications
  • History of cancer undergoing active treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Putra Malaysia

Serdang, Selangor, 43400, Malaysia

RECRUITING

Related Publications (11)

  • Babineaux SM, Toaima D, Boye KS, Zagar A, Tahbaz A, Jabbar A, Hassanein M. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med. 2015 Jun;32(6):819-28. doi: 10.1111/dme.12685. Epub 2015 Apr 10.

    PMID: 25581456BACKGROUND
  • Bujang MA, Ismail M, Hatta NKBM, Othman SH, Baharum N, Lazim SSM. Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus. Malays J Med Sci. 2017 Aug;24(4):86-96. doi: 10.21315/mjms2017.24.4.10. Epub 2017 Aug 18.

    PMID: 28951693BACKGROUND
  • Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000 Sep 16;321(7262):694-6. doi: 10.1136/bmj.321.7262.694. No abstract available.

    PMID: 10987780BACKGROUND
  • Hamdy O, Barakatun-Nisak MY. Nutrition in Diabetes. Endocrinol Metab Clin North Am. 2016 Dec;45(4):799-817. doi: 10.1016/j.ecl.2016.06.010.

    PMID: 27823606BACKGROUND
  • Lee JY, Wong CP, Tan CSS, Nasir NH, Lee SWH. Type 2 diabetes patient's perspective on Ramadan fasting: a qualitative study. BMJ Open Diabetes Res Care. 2017 May 8;5(1):e000365. doi: 10.1136/bmjdrc-2016-000365. eCollection 2017.

    PMID: 28761651BACKGROUND
  • Lee SWH, Lee JY, Tan CSS, Wong CP. Strategies to Make Ramadan Fasting Safer in Type 2 Diabetics: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Observational Studies. Medicine (Baltimore). 2016 Jan;95(2):e2457. doi: 10.1097/MD.0000000000002457.

    PMID: 26765440BACKGROUND
  • Lee JY, Wong CP, Tan CSS, Nasir NH, Lee SWH. Telemonitoring in fasting individuals with Type 2 Diabetes Mellitus during Ramadan: A prospective, randomised controlled study. Sci Rep. 2017 Aug 31;7(1):10119. doi: 10.1038/s41598-017-10564-y.

    PMID: 28860546BACKGROUND
  • Lessan N, Hannoun Z, Hasan H, Barakat MT. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab. 2015 Feb;41(1):28-36. doi: 10.1016/j.diabet.2014.11.004. Epub 2014 Dec 10.

    PMID: 25497966BACKGROUND
  • Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004 Oct;27(10):2306-11. doi: 10.2337/diacare.27.10.2306.

    PMID: 15451892BACKGROUND
  • Hassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, Al-Madani A, Hanif W, Lessan N, Basit A, Tayeb K, Omar M, Abdallah K, Al Twaim A, Buyukbese MA, El-Sayed AA, Ben-Nakhi A; International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Diabetes and Ramadan: Practical guidelines. Diabetes Res Clin Pract. 2017 Apr;126:303-316. doi: 10.1016/j.diabres.2017.03.003. Epub 2017 Mar 12.

    PMID: 28347497BACKGROUND
  • Jadviscokova T, Fajkusova Z, Pallayova M, Luza J, Kuzmina G. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Dec;151(2):263-6. doi: 10.5507/bp.2007.044.

    PMID: 18345261BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Barakatun-Nisak Mohd Yusof, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Wan Zul Haikal Hafiz Wan Zukiman, Mmed

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Noraida Omar, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Zalina Abu Zaid, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Azrina Azlan, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Firdaus Mamat @ Mukhtar, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Norhasmah Sulaiman, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Siti NurA'syura Adznam, PhD

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Nur Maziah Hanum Osman, Master

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Nor Farahain Yahya, Degree

    Universiti Putra Malaysia

    PRINCIPAL INVESTIGATOR
  • Osama Hamdy, MD, PhD

    Joslin Diabetes Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Barakatun-Nisak Mohd Yusof, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants are assigned to two groups in parallel for the duration of the study based on their choice
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 9, 2019

First Posted

January 25, 2019

Study Start

April 1, 2019

Primary Completion

December 1, 2019

Study Completion

December 30, 2019

Last Updated

August 12, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

The data is subjected to privacy

Locations